arthritis-research.com/article
Bottom,Top,Right1
  • Log on
  •   BioMed Central
  • Journals
  • Gateways
Arthritis Research & Therapy
official impact factor 4.45
Search for
Advanced search
  • Home
  • Articles
  • Authors
  • Reviewers
  • About this journal
  • My Arthritis Research & Therapy
  • Subscriptions

Submit a manuscript Register Sign up for article alerts Contact us Follow us on Twitter

Explore journal

  •  Editorial Board
  •  Instructions for authors
  •  FAQ
Advertisement

Articles

  • All articles
  • Most viewed RSS
      • Last 30 days
      • Last year
      • All time
  • Issues
  • Supplements
  • Article collections

Page 4 of 4

 Previous 1 2 3 4

 Display/download options Articles per page: 25 | 50 | 100

Display options
Download optionsHelp icon

76.

14280
Accesses

Review   Free Highly Accessed

Relevance of the stroma and epithelial-mesenchymal transition (EMT) for the rheumatic diseases

Nathan J Zvaifler Arthritis Research & Therapy 2006, 8:210 (9 May 2006)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

77.

14235
Accesses

Review   Free Highly Accessed

Biology of RANK, RANKL, and osteoprotegerin

Brendan F Boyce, Lianping Xing Arthritis Research & Therapy 2007, 9(Suppl 1):S1 (29 June 2007)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

78.

14208
Accesses

Research article   Open Access

Hormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin-like growth factor 1

Helena d'Elia, Lars-Åke Mattsson, Claes Ohlsson, Elisabeth Nordborg, Hans Carlsten Arthritis Res Ther 2003, 5:R202-R209 (1 May 2003)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

79.

14074
Accesses

Research article   Open Access Highly Accessed

A pilot study of IL-1 inhibition by anakinra in acute gout

Alexander So, Thibaut De Smedt, Sylvie Revaz, Jürg Tschopp Arthritis Research & Therapy 2007, 9:R28 (12 March 2007)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

In a pilot study on 10 patients with gouty arthritis, IL-1 blockade with anakinra gave rapid relief of inflammatory symptoms where standard treatments had failed or were not tolerated.

80.

14050
Accesses

Review   Free Highly Accessed

Biology and therapy of fibromyalgia. Stress, the stress response system, and fibromyalgia

Manuel Martinez-Lavin Arthritis Research & Therapy 2007, 9:216 (6 July 2007)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

81.

14032
Accesses

Review   Free Highly Accessed

Gout. Novel therapies for treatment of gout and hyperuricemia

Robert Terkeltaub Arthritis Research & Therapy 2009, 11:236 (23 July 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

82.

14000
Accesses

Research article   Open Access

Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset

Raphaela Goldbach-Mansky, Jennifer Lee, Angela McCoy, Joseph Hoxworth, Cheryl Yarboro, Josef S Smolen, Günter Steiner, Antony Rosen, Cindy Zhang, Henri A Ménard, Zhi Jie Zhou, Timo Palosuo, Walther J Van Venrooij, Ronald L Wilder, John H Klippel, H Ralph Schumacher, Hani S El-Gabalawy Arthritis Res 2000, 2:236-243 (31 March 2000)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

83.

13981
Accesses

Review   Free Highly Accessed

Oxidation in rheumatoid arthritis

Carol A Hitchon, Hani S El-Gabalawy Arthritis Res Ther 2004, 6:265-278 (13 October 2004)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

84.

13974
Accesses

Commentary   Free Highly Accessed

Does a positive anti-CCP test identify a distinct arthritis entity?

Thomas Skogh Arthritis Research & Therapy 2005, 7:230-232 (16 September 2005)

Abstract | Full text | PDF | PubMed

85.

13954
Accesses

Review   Free Highly Accessed

Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management

Flavia V Castelino, John Varga Arthritis Research & Therapy 2010, 12:213 (23 August 2010)

Abstract | Full text | PDF | PubMed

86.

13705
Accesses

Research article   Open Access Highly Accessed

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

Michael A Becker, H Ralph Schumacher, Luis R Espinoza, Alvin F Wells, Patricia MacDonald, Eric Lloyd, Christopher Lademacher Arthritis Research & Therapy 2010, 12:R63 (6 April 2010)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

87.

13651
Accesses

Research article   Open Access Highly Accessed

Identification of blood biomarkers of rheumatoid arthritis by transcript profiling of peripheral blood mononuclear cells from the rat collagen-induced arthritis model

Jianyong Shou, Christopher M Bull, Li Li, Hui-Rong Qian, Tao Wei, Shuang Luo, Douglas Perkins, Patricia J Solenberg, Seng-Lai Tan, Xin-Yi Chen, Neal W Roehm, Jeffrey A Wolos, Jude E Onyia Arthritis Research & Therapy 2006, 8:R28 (10 January 2006)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

88.

13627
Accesses

Research article   Open Access Highly Accessed

Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period

Juan J Gomez-Reino, Loreto Carmona, the BIOBADASER Group Arthritis Research & Therapy 2006, 8:R29 (6 January 2006)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

89.

13610
Accesses

Review   Free

Perspectives for TNF-α-targeting therapies

Hanns-Martin Lorenz, Joachim R Kalden Arthritis Res 2002, 4(Suppl 3):S17-S24 (9 May 2002)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

90.

13371
Accesses

Review   Free

Angiogenesis in rheumatoid arthritis

Ewa M Paleolog Arthritis Res 2002, 4(Suppl 3):S81-S90 (9 May 2002)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

91.

13357
Accesses

Review   Free Highly Accessed

The life cycle of chondrocytes in the developing skeleton

Lillian Shum, Glen Nuckolls Arthritis Res 2002, 4:94-106 (8 November 2001)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

92.

13244
Accesses

Review   Free Highly Accessed

The evolving clinical profile of abatacept (CTLA4–Ig): a novel co-stimulatory modulator for the treatment of rheumatoid arthritis

Eric M Ruderman, Richard M Pope Arthritis Research & Therapy 2005, 7(Suppl 2):S21-S25 (16 March 2005)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

93.

13166
Accesses

Research article   Open Access Highly Accessed

Collagen-induced arthritis in C57BL/6 mice is associated with a robust and sustained T-cell response to type II collagen

Julia J Inglis, Gabriel Criado, Mino Medghalchi, Melanie Andrews, Ann Sandison, Marc Feldmann, Richard O Williams Arthritis Research & Therapy 2007, 9:R113 (29 October 2007)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

C57BL/6 mice may be useful for testing new therapeutics, particularly those directed against T cells, and investigating the action of current therapies in rheumatoid arthritis.

94.

13067
Accesses

Research article   Open Access Highly Accessed

Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells

Kutty Nandakumar, Johan Bäcklund, Mikael Vestberg, Rikard Holmdahl Arthritis Res Ther 2004, 6:R544-R550 (23 September 2004)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

95.

13011
Accesses

Research article   Open Access Highly Accessed

Forced mobilization accelerates pathogenesis: characterization of a preclinical surgical model of osteoarthritis

C Thomas G Appleton, David D McErlain, Vasek Pitelka, Neil Schwartz, Suzanne M Bernier, James L Henry, David W Holdsworth, Frank Beier Arthritis Research & Therapy 2007, 9:R13 (6 February 2007)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

96.

13010
Accesses

Research article   Open Access Highly Accessed

Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides

Merete Pedersen, Søren Jacobsen, Mette Klarlund, Bo V Pedersen, Allan Wiik, Jan Wohlfahrt, Morten Frisch Arthritis Research & Therapy 2006, 8:R133 (27 July 2006)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

97.

13001
Accesses

Research article   Open Access Highly Accessed

Rheumatic Diseases in China

Qing Zeng, Ren Chen, John Darmawan, Zheng Xiao, Su Chen, Richard Wigley, Shun Le Chen, Nai Zhang Arthritis Research & Therapy 2008, 10:R17 (31 January 2008)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

A large population study found that the incidence of certain rheumatic diseases in China is becoming more like that of Western countries, but different joints are affected compared to Caucasian populations.

98.

12992
Accesses

Review   Free Highly Accessed

Epstein–Barr virus and rheumatoid arthritis: is there a link?

Karen H Costenbader, Elizabeth W Karlson Arthritis Research & Therapy 2006, 8:204 (16 January 2006)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

99.

12949
Accesses

Supplement   Free

Autoantibodies in rheumatoid arthritis and their clinical significance

Günter Steiner, Josef Smolen Arthritis Res 2002, 4(Suppl 2):S1-S5 (26 April 2002)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

100.

12925
Accesses

Research article   Open Access Highly Accessed

Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study

Jacques Tebib, Xavier Mariette, Pierre Bourgeois, René-Marc Flipo, Philippe Gaudin, Xavier Le Loët, Paul Gineste, Laurent Guy, Colin D Mansfield, Alain Moussy, Patrice Dubreuil, Olivier Hermine, Jean Sibilia Arthritis Research & Therapy 2009, 11:R95 (23 June 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

A small clinical trial has shown masitinib to be generally well tolerated and effective in the treatment of rheumatoid arthritis, indicating the need for further placebo-controlled studies.

Page 4 of 4

 Previous 1 2 3 4


  • Terms and Conditions
  • Privacy statement
  • Press
  • Information for advertisers
  • Jobs at BMC
  • Support
  • Contact us

© 2013 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.